Compliance Rate

Compliance Rate 50.0%
Compliant submissions 3
Incompliant submissions 3
Total trials 6

My Organizations' Clinical Trials

Showing 275 of 1157 entries
View as:

Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

Phase: N/A Priority: Normal
NCT ID: NCT03561584 Org: User:
Start: 07/01/18 End: 11/01/24 Due: 11/01/25

Ketamine for OUD and Suicidal Ideation in the ED

Phase: N/A Priority: Normal
NCT ID: NCT06111339 Org: User:
Start: 06/14/24 End: 03/31/25 Due: 03/31/26

Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis

Phase: N/A Priority: Normal
NCT ID: NCT03675022 Org: User:
Start: 08/15/18 End: 07/01/22 Due: 07/01/23

Brigham and Women's Rheumatoid Arthritis Sequential Study

Phase: N/A Priority: Normal
NCT ID: NCT01793103 Org: User:
Start: 03/31/03 End: 03/31/28 Due: 03/31/29

Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women

Phase: N/A Priority: Normal
NCT ID: NCT00900367 Org: User:
Start: 07/31/05 End: 12/31/25 Due: 12/31/26

Preventing Cardiac Surgery Readmission With Patient Activity Tracking Technology

Phase: N/A Priority: Normal
NCT ID: NCT04348981 Org: User:
Start: 06/01/20 End: 07/31/22 Due: 07/31/23

Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2

Phase: N/A Priority: Normal
NCT ID: NCT01867788 Org: User:
Start: 09/30/12 End: 09/30/17 Due: 09/30/18

Isolation of Cells From Biopsy Tissue to Aid in Kidney Repair

Phase: N/A Priority: Normal
NCT ID: NCT04896567 Org: User:
Start: 01/21/22 End: 12/30/24 Due: 12/30/25

Study of Perfusion and Anatomy's Role in Coronary Artery (CAD)

Phase: N/A Priority: Normal
NCT ID: NCT00321399 Org: User:
Start: 06/30/06 End: 07/31/14 Due: 07/31/15

Sirtuin-NAD Activator in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05040321 Org: User:
Start: 12/01/21 End: 12/31/25 Due: 12/31/26

Trial of Pistachio Consumption in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT06992544 Org: User:
Start: 05/28/25 End: 06/30/26 Due: 06/30/27

Effects of Performance Feedback on Imaging Use in the Emergency Department

Phase: N/A Priority: Normal
NCT ID: NCT02283086 Org: User:
Start: 01/31/12 End: 12/31/13 Due: 12/31/14

Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants

Phase: N/A Priority: Normal
NCT ID: NCT01853111 Org: User:
Start: 03/01/14 End: 03/10/20 Due: 03/10/21

Replication of the P04334 Asthma Trial in Healthcare Claims Data

Phase: N/A Priority: Normal
NCT ID: NCT04892758 Org: User:
Start: 10/29/20 End: 06/11/21 Due: 06/11/22

Multi-Center Medication Reconciliation Quality Improvement Study

Phase: N/A Priority: Normal
NCT ID: NCT01337063 Org: User:
Start: 03/31/11 End: 09/30/14 Due: 09/30/15

Using mHealth Technology to Identify and Refer Surgical Site Infections in Rwanda

Phase: N/A Priority: Normal
NCT ID: NCT03311399 Org: User:
Start: 03/15/17 End: 10/04/18 Due: 10/04/19

Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion

Phase: N/A Priority: Normal
NCT ID: NCT04574388 Org: User:
Start: 11/30/18 End: 03/10/20 Due: 03/10/21

Study on Allopregnanolone and Depression in Perimenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT05329779 Org: User:
Start: 11/04/22 End: 05/01/26 Due: 05/01/27

Replication of the DECLARE Diabetes Trial in Healthcare Claims

Phase: N/A Priority: Normal
NCT ID: NCT04215523 Org: User:
Start: 07/08/19 End: 02/18/21 Due: 02/18/22

A Positive Psychology Intervention for Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03637699 Org: User:
Start: 03/12/18 End: 04/09/19 Due: 04/09/20

Achieving Diagnostic Excellence Through Prevention and Teamwork

Phase: N/A Priority: Normal
NCT ID: NCT05747755 Org: User:
Start: 03/31/23 End: 09/30/26 Due: 09/30/27

Treatment of Refractory Status Epilepticus

Phase: N/A Priority: Normal
NCT ID: NCT00265616 Org: User:
Start: 05/31/06 End: 03/31/10 Due: 03/31/11

Sleep Well: Digital Insomnia Treatment Program For Physicians

Phase: N/A Priority: Normal
NCT ID: NCT05289596 Org: User:
Start: 02/04/22 End: 07/31/22 Due: 07/31/23

Effects of Vitamin D and Omega-3 on Cerebrovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT04070833 Org: User:
Start: 08/01/16 End: 09/17/18 Due: 09/17/19

VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL

Phase: N/A Priority: Normal
NCT ID: NCT01696435 Org: User:
Start: 07/31/10 End: 04/30/25 Due: 04/30/26